Metabolic-Fit / 100
Spry review
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, no pharmacy named, no state list disclosed, and nothing written for postpartum or PCOS specifically. Its pricing only surfaces from the site's own compiled JavaScript rather than the visible marketing page, which is how it was confirmed for this review.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Spry at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
How we scored Spry
Each factor is scored from Spry's real pricing, disclosures and oversight, then combined into the 38/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- becomespry.com
Live-verified 2026-08-05. becomespry.com renders client-side, so pricing, molecule names, named co-founders, and the 'FDA Approved' badge were confirmed by fetching and reading its compiled JS bundle directly. $199/mo semaglutide and $299/mo tirzepatide confirmed; named co-founders Gabriel Mullins, Sara Yoder, and Tyler Bowman confirmed in-bundle. The 'FDA Approved' badge and copy are real and recorded honestly in cons as a labeling-accuracy concern, not conflated with an actual FDA warning letter — no warning letter was found for Spry / becomespry.com in a direct search.
What to expect when you sign up
We walked Spry's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1becomespry.com is a client-rendered app — pricing was confirmed by pulling and reading its actual JS bundle, not just the marketing page
- 2Three co-founders are named on-site: Gabriel Mullins, Sara Yoder, and Tyler Bowman
- 3No contracts required; a nurse practitioner reviews intake within roughly 24 hours per Spry's own claims
- 4Also sells three longevity peptides alongside its GLP-1 program
What we noticed
- Spry's homepage displays an 'FDA Approved' badge and 'FDA-approved treatments' copy — but compounded semaglutide and tirzepatide are not themselves FDA-approved finished drug products; worth reading that badge skeptically
- Three named co-founders is more personal accountability than most compounded-GLP-1 storefronts show
- No state-availability list found, and no pharmacy is named beyond 'FDA-registered compounding facilities' generically
- Nothing on the site addresses pregnancy, breastfeeding, postpartum timing, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Starting tierConfirmed live by pulling Spry's own JS bundle (becomespry.com is a client-rendered app). |
| Compounded tirzepatide | $299 | Starting tierConfirmed the same way. Spry also sells three longevity peptides (BPC-157, NAD+, sermorelin) at $249-$299/mo — not GLP-1s, so left out of these rows rather than mis-tagged. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Spry's public disclosures at last review and change often; confirm the current number on Spry's own site.
What we like
- Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
- No contracts required, with a stated ~24-hour nurse practitioner review of intake
- Also offers three longevity peptides if that's of interest beyond weight loss
The caveats
- Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
- No pharmacy named, and no state-availability list found
- Nothing written specifically for postpartum, breastfeeding, or PCOS
Spry for mothers: our verdict
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, no pharmacy named, no state list disclosed, and nothing written for postpartum or PCOS specifically. Its pricing only surfaces from the site's own compiled JavaScript rather than the visible marketing page, which is how it was confirmed for this review. It runs about $199/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Spry the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Spry actually costs
- Compounded semaglutide — Starting tier: $199/mo
- Compounded tirzepatide — Starting tier: $299/mo
For context, the typical ongoing price across our roster is around $172/month, so Spry sits at the premium end.
The medications Spry prescribes
Spry prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Spry fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Spry is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who likes seeing named founders behind a brand and will read the 'FDA Approved' badge skeptically rather than at face value.
Alternatives to Spry
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Spry
Head-to-head & alternatives
Spry, answered
- How much does Spry cost?
- As last verified, Spry's compounded pricing starts around $199/month ($199/mo semaglutide, $299/mo tirzepatide). Confirm the current, all-in price on Spry's own site before you commit.
- Is Spry safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use; Spry is no exception. Plan any GLP-1 for after weaning, and discuss the timing with your own clinician.
- Does Spry offer both semaglutide and tirzepatide?
- Yes — Spry offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Spry rank for mothers?
- Spry scores 38/100 on our Metabolic-Fit Score (rank #104), which weights six factors that matter for mothers. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect Spry's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.